Jessica Visit 1: 35-Year-Old White Female with Persistent Back and Foot Pain
Rheumatologists; Physicians
Jessica Visit 1: 35-Year-Old White Female with Persistent Back and Foot Pain
Supported by an educational donation provided by Amgen and Wyeth Pharmaceuticals.
Faculty
Jonathon Kay, MD
Professor of Medicine
University of Massachesettes Medical School
Worcester, Massachusettes
Philip Mease, MD
Director, Rhuematology Research Swedish Medical Center Clinical Professor University of Washington Seattle, Washington
Intended Learners
This activity is designed for Rheumatologists and Physicians.
Learning Objectives
Upon completion of the activity, participants should be able to:
- Explain how clinical measurement tools have been used to achieve tight spondyloarthopathy (SpA) control and summarize how these tools can be used in clinical practice to optimize patient care
- Describe advances in imaging techniques for the diagnosis of SpA and evaluation of disease progression
- Outline genetic associations, laboratory markers, and clinical manifestations which should be considered when initiating early, aggressive therapy
- Compare and contrast diagnostic practices and treatment approaches for patients with SpA versus rheumatoid arthritis (RA)
Activity Overview
To be eligible for credit, participants must complete the educational activity, complete the 5-question online post-test with a score of 80% or better, and complete the evaluation form. After successful completion of the post-test and evaluation form online, participants may immediately print their documentation of credit.
There is no fee associated with this activity.
Estimated time to completion: 0.75hrs.
For questions regarding this educational activity, please contact info@naccme.com.
Hardware/Software Requirements
Internet Explorer (v6 or greater), or Firefox
Safari
Please direct technical questions to webmaster@naccme.com.
CME Accredidation
The University of Cincinnati is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of Cincinnati designates this educational activity for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Planning Committee
Financial Disclosure and Conflicts of Interest
According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.
All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.
The faculty has reported the following:
Dr. Hashefi: Has disclosed no relevant financial relationships with any commercial interests.
Planning Committee members Ms. Weigand, Mr. Robbin, Ms. McCardell, Mr. Savage, and Mr. Kormos have reported no relevant financial relationships with any commercial interests
NACCME requires faculty to inform participants whenever off-label/unapproved uses of drugs and/or devices are discussed in their presentation.
Faculty have disclosed that the use of diclofenac, methotrexate, naproxen sodium, sulfasalazine, and NSAIDs for the treatment of spondyloarthropathy will be discussed.
Private Policy
Grant Support
© Copyright 2011 North American Center for Continuing Medical Education, LLC